A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease

This publication has 27 references indexed in Scilit:

• ACC/AHA guidelines for the management of patients with acute myocardial infarction
  Journal of the American College of Cardiology, 1996
• Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardial infarction
  American Heart Journal, 1996
• Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: A coronary care unit experience
  American Heart Journal, 1994
• Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)
  Journal of the American College of Cardiology, 1992
• Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.
  Heart, 1992
• Heparin
  New England Journal of Medicine, 1991
• A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial Infarction
  New England Journal of Medicine, 1990
• Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction
  The American Journal of Cardiology, 1987
• Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis
  New England Journal of Medicine, 1986
• Assessment of Anticoagulant Treatment of Venous Thromboembolism
  Annals of Surgery, 1969